Second, we showed that BMP7 treatment suppresses the expression of TNF-alpha, which is the main promoter of bone loss in patients with IBD, suggesting that these effects were the repercussion of the established anti-inflammatory role of BMP7 [28]. The gene discussed is TNF; the disease is inflammatory bowel disease.